A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/2006
12/20/2006	EP1732516A1 Ion binding compositions
12/20/2006	EP1732512A2 Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
12/20/2006	EP1732511A1 Ophthalmic solution comprising sodium carboxymethylcellulose and hydroxypropylmethylcellulose
12/20/2006	EP1732486A1 Drug-enhanced adhesion prevention
12/20/2006	EP1732485A2 Encapsulation of chemical compounds in fluorous-core and fluorous-inner-shell micelles formed from semifluorinated-block or fluorinated-block copolymers
12/20/2006	EP1732382A2 Sfec, a sperm flagellar energy carrier protein
12/20/2006	EP1594979A4 Nanocylinder-modified surfaces
12/20/2006	EP1523335B1 Injectable depot formulation comprising crystals of iloperidone
12/20/2006	EP1519745B1 Method to enhance an immune response of nucleic acid vaccination
12/20/2006	EP1496095B1 Refrigerant compositions and uses thereof
12/20/2006	EP1474152B1 Orodispersible pharmaceutical composition comprising ivabradine
12/20/2006	EP1379235B1 Compositions and methods for enhancing paracellular permeability across epithelial and endothelial barriers
12/20/2006	EP1357903B1 STABILIZED FORMULATIONS OF 6-HYDROXY-3-(4- 2-(PIPERIDIN-1-YL) ETHOXY\|PHENOXY)-2-(4-METHOXYPHENYL) BENZO b\|THIOPHENE AND SALTS THEREOF
12/20/2006	EP1353696B1 Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
12/20/2006	EP1343473B1 Pharmaceutical dronedarone composition for parenteral administration
12/20/2006	EP1299537B1 Compounds targeted to cellular locations
12/20/2006	EP1276472B1 Formulations for use in inhaler devices
12/20/2006	EP1121103B1 Orally disintegrable tablets comprising a benzimidazole
12/20/2006	EP1023075B1 Liquid presentations of oxazaphosphorine-containing pharmaceutical products
12/20/2006	EP0943326B2 Powdery composition for nasal administration
12/20/2006	CN1882693A Polyethyleneglycol-modified lipid compounds and uses thereof
12/20/2006	CN1882523A Novel phenol derivative, and anti-trypanosomiasis medicine with the phenol derivative as effective ingredient
12/20/2006	CN1882508A Process for preparing water soluble diterpenes and their applications
12/20/2006	CN1882362A Method for delivery of an active drug to the posterior part of the eye via subconjunctival or periocular delivery of a prodrug
12/20/2006	CN1882361A Delivery system for active components as part of an edible composition having preselected tensile strength
12/20/2006	CN1882360A The use of antibiotics as vaccine adjuvants
12/20/2006	CN1882356A Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices
12/20/2006	CN1882349A Aqueous solution preparation containing aminoglycoside antibiotic and bromfenac
12/20/2006	CN1882346A Solid dispersion or medicinal solid dispersion preparation of phenylalanine derivative
12/20/2006	CN1882341A Method and composition for treatment of cutaneous lesions
12/20/2006	CN1882322A Patch
12/20/2006	CN1882321A Pellets containing venlafaxine hydrochloride
12/20/2006	CN1882309A Use of perfluoropolyether phosphates as stabilizing agents for polyphenols in cosmetic and/or dermatological compositions
12/20/2006	CN1880334A High purity albumin production process
12/20/2006	CN1879890A Use of methioninase in anti-methionine and anti-homocysteine chemotherapy
12/20/2006	CN1879889A Kidney-targeted medicine vector and the formed prodrug, preparation method and uses
12/20/2006	CN1879888A Transdermal drug administration intensifier and its usage method
12/20/2006	CN1879887A Insoluble drug delivery system based on water-soluble cyclodextrin
12/20/2006	CN1879886A Sodium acetylide/ soybean separation protein commixed gel granule preparation method
12/20/2006	CN1879876A Neurotrophic factor slow release microsphere and its preparation method
12/20/2006	CN1879875A Preparations stabilized over long time
12/20/2006	CN1879691A 'Fu Yan Jing' film for treating gynecological inflammation and preparation method thereof
12/20/2006	CN1879682A Film for treating oral ulcer and preparation method thereof
12/20/2006	CN1879665A Quickly-acting defervescence plaster used for infants and preparation method thereof
12/20/2006	CN1879656A Solid water soluble propolis composition and preparation method thereof
12/20/2006	CN1879647A Solid dispersion of protopanaxadiol and preparation method thereof
12/20/2006	CN1879635A Beta-cyclodextrin inclusion compound of adefovir dipivoxil and preparation thereof
12/20/2006	CN1879627A A sustained release injection containing cephalosporin and application thereof
12/20/2006	CN1879620A A sustained release injection containing penicillins antibiotic and application thereof
12/20/2006	CN1879618A Compound paracetamol injection for animal and preparation method thereof
12/20/2006	CN1879612A Nano particles of taxane cyclodextrin inclusion compound and preparation method thereof
12/20/2006	CN1879610A Method for preparing oral administered sustained-release peptide micro capsule
12/20/2006	CN1879609A A method for preparing silk fibroin Vitamin E contained micro capsule
12/20/2006	CN1879608A Bioadhesive progressive hydration tablets
12/20/2006	CN1879607A A sodium alginate microsphere vascular embolizing agent containing water soluble drug, its preparation and application
12/20/2006	CN1879604A An antibiotics-containing sustained releasing injection and application thereof
12/20/2006	CN1879603A Compound micro-cream for acne treatment and preparation method thereof
12/20/2006	CN1879507A Water containing soluble fiber
12/20/2006	CN1290907C A method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge
12/20/2006	CN1290906C Hydrophilic porous polymer beads and method of production thereof
12/20/2006	CN1290893C Polymeric microemulsions
12/20/2006	CN1290582C Biodegradable chitosan slow-release material
12/20/2006	CN1290507C Steroid hormone products and preparing method thereof
12/20/2006	CN1290506C Medicinal composition
12/20/2006	CN1290505C PH sensitive controllable nanometer particle carried with 5-Fu and its preparation method
12/20/2006	CN1290502C Compositions for treatment of common cold
12/20/2006	CN1290488C Application of micro bubble reagent for blood vessel embolism operation induced by ultrasonic and fat-reducing beautifying operation
12/19/2006	US7151191 Such as 3-(4-salicyloylamino)phenoxypropionic acid; noncovalent drug delivery
12/19/2006	US7151162 Capable of interacting with wnt-signalling pathway (beta-catenins and T-cell factors); cancer diagnosis
12/19/2006	US7151135 biocompatible, synthetic, and nonimmunogenic, crosslinkable polymer compositions of a first synthetic polymer containing multiple nucleophilic groups and a second synthetic polymer containing multiple electrophilic groups; use as implant coatings, preventing surgical adhesions
12/19/2006	US7150883 Liposome suspension forms spontaneously upon adding a diacylglycerol-PEG lipid to an aqueous solution when the lipid has appropriate packing parameters and the adding occurs above the melting temperature of the lipid
12/19/2006	US7150882 Enhanced circulation effector composition and method
12/19/2006	US7150872 Chemical modification of single chain polypeptides by means of covalent attachment of strands of polyethylene glycol to single chain polypeptide binding molecules that have three dimensional folding and binding ability
12/19/2006	US7150870 Treatment of tumors with superoxide dismutase for prevention by applying to tumors
12/19/2006	US7150869 Gene therapy; cytokine complex; anticancer agent
12/19/2006	US7150867 Radionuclide-coated particulate material
12/19/2006	US7150766 Method of particle formation
12/19/2006	CA2364610C Pharmaceutical solubilized in aerosol propellant
12/19/2006	CA2358062C Controlled release galantamine composition
12/19/2006	CA2320087C Treatment of chronic inflammatory disorders of the gastrointestinal tract
12/19/2006	CA2301577C Glucose-containing preparation
12/19/2006	CA2251623C Buccal delivery system
12/19/2006	CA2251169C Quaternary cytofectins
12/19/2006	CA2232880C Semi-fluorinated alkanes and their use
12/19/2006	CA2212537C Therapeutic inhibitor of vascular smooth muscle cells
12/19/2006	CA2200966C Pharmaceutical compositions
12/19/2006	CA2194761C Immunomodulatory oligonucleotides
12/19/2006	CA2188297C Lactone stable formulation of camptothecin or 7-ethyl camptothecin
12/19/2006	CA2162208C Percutaneous absorption preparation
12/14/2006	WO2006132870A1 Ophthalmic solution with a flavoring agent
12/14/2006	WO2006132868A1 Ophthalmic solution with a flavoring agent as a dosing indicator and method for indicating dosage of an ophthalmic solution
12/14/2006	WO2006132440A1 Solid preparation
12/14/2006	WO2006132403A1 Mri contrast medium containing liposomes
12/14/2006	WO2006132398A1 Capsule coating composition
12/14/2006	WO2006132388A1 Bone marrow-directing drug delivery materials and their applications
12/14/2006	WO2006132363A1 Stabilizer for protein preparation comprising meglumine and use thereof
12/14/2006	WO2006132360A1 Sugar-coated tablet
12/14/2006	WO2006132352A1 Pharmaceutical composition containing sc(fv)2
12/14/2006	WO2006132342A1 Eye drop containing roflumilast
12/14/2006	WO2006132307A1 Stabilized milnacipran formulation

1 ... 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 ... 1712